Abzena is a leading partner research organization offering a comprehensive suite of services for the development and GMP manufacturing of biopharmaceuticals, including complex antibodies and antibody-drug conjugates (ADCs). They support clients from early-stage discovery through to clinical and commercial manufacturing, aiming to accelerate the delivery of innovative medicines to patients. Their expertise spans immunology, protein engineering, cell line development, process development, conjugation technologies, and cGMP manufacturing.
Registered global headquarters and a key research site, focusing on discovery services including antibody and protein engineering and immunogenicity assessment.
Located within the prestigious Babraham Research Campus, a leading UK life sciences hub, offering access to state-of-the-art research facilities and a vibrant scientific community.
A science-driven, innovative, and collaborative environment dedicated to advancing biopharmaceutical development. Emphasis is placed on quality, scientific excellence, and teamwork.
Serves as the official corporate headquarters and a vital center for Abzena's early-stage discovery and research operations, underpinning its integrated service model.
Abzena operates multiple state-of-the-art facilities strategically located in the United Kingdom (Cambridge - Babraham Research Campus and Granta Park) and the United States (San Diego, CA - multiple sites; Bristol, PA; and Langhorne, PA). These sites function cohesively to provide global biopharmaceutical clients with comprehensive, integrated solutions ranging from early discovery and engineering of biologics and ADCs, through process development, analytical testing, and GMP manufacturing for both clinical trials and commercial supply.
Building 900, Babraham Research Campus
Babraham, Cambridge
Cambridgeshire
United Kingdom
Address: Granta Park, Great Abington, Cambridge, CB21 6GS, UK
Key European hub for later-stage development and manufacturing support services, complementing the discovery services at Babraham.
Address: 10150 Meanley Drive, San Diego, CA 92131, USA
Primary North American hub for clinical and commercial scale biologics drug substance manufacturing and supporting development services.
Address: 3 Headley Road, Bristol, PA 19007, USA
Center of excellence for ADC development and manufacturing in North America, addressing the complex needs of bioconjugate production.
Address: 2100 Cabot Boulevard West, Langhorne, PA 19047, USA
Supports North American and global clients with microbial fermentation and purification capabilities for diverse biopharmaceutical products.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Abzena' leadership includes:
Abzena has been backed by several prominent investors over the years, including:
Abzena has experienced key executive transitions in the last 12-18 months, notably appointing a new Chief Financial Officer (May 2023) and a new Chief Commercial Officer (January 2024). These changes signify strategic leadership refreshment in its financial and commercial operations.
Discover the tools Abzena uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Abzena commonly uses the 'first.last@abzena.com' email format for its employees. While other formats might exist within the organization, this structure is widely observed and considered primary.
first.last@abzena.com
Format
jane.doe@abzena.com
Example
85%
Success rate
PR Newswire • January 9, 2024
Abzena appointed Troy Wright as its new Chief Commercial Officer. Wright brings extensive experience in the biopharmaceutical and CDMO sectors to lead Abzena's global commercial strategy and execution, aiming to enhance customer engagement and market presence....more
Business Wire • July 11, 2023
Abzena announced the completion of an expansion at its San Diego, CA site, adding a new 2,000L STR bioreactor train for mammalian drug substance manufacturing. This expansion significantly increases its cGMP capacity to meet growing client demand for clinical and commercial biologics....more
PR Newswire • May 16, 2023
Abzena announced the appointment of Richard Milnes as Chief Financial Officer. Milnes brings over 20 years of financial leadership experience in the life sciences and healthcare industries, tasked with steering Abzena's financial strategy and operations during its growth phase....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Abzena, are just a search away.